Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
The activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) gl...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/7940 |
id |
doaj-d3e6b69348b841cdb807d3ae248b1fca |
---|---|
record_format |
Article |
spelling |
doaj-d3e6b69348b841cdb807d3ae248b1fca2021-08-06T15:24:49ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-01227940794010.3390/ijms22157940Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)Marta Marszalek-Grabska0Irena Smaga1Paulina Surowka2Pawel Grochecki3Tymoteusz Slowik4Malgorzata Filip5Jolanta H. Kotlinska6Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandAffective Cognitive Neuroscience Laboratory, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandDepartment of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, PolandExperimental Medicine Center, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, PolandDepartment of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, PolandThe activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) glutamate receptors regulate the ability of a priming dose of WIN 55,212-2 to cross-reinstate ethanol-induced conditioned place preference (CPP). To test this hypothesis, ethanol-induced (1.0 g/kg, 10% <i>w</i>/<i>v</i>, i.p.) CPP (unbiased method) was established using male adult Wistar rats. After CPP extinction, one group of animals received WIN 55,212-2 (1.0 and 2.0 mg/kg, i.p.), the cannabinoid receptor 1 (CB1) agonist, or ethanol, and the other group received memantine (3.0 or 10 mg/kg, i.p.), the NMDA antagonist and WIN 55,212-2 on the reinstatement day. Our results showed that a priming injection of WIN 55,212-2 (2.0 mg/kg, i.p.) reinstated (cross-reinstated) ethanol-induced CPP with similar efficacy to ethanol. Memantine (3.0 or 10 mg/kg, i.p.) pretreatment blocked this WIN 55,212-2 effect. Furthermore, our experiments indicated that ethanol withdrawal (7 days withdrawal after 10 days ethanol administration) down-regulated the CNR1 (encoding CB1), GRIN1/2A (encoding GluN1 and GluN2A subunit of the NMDA receptor) genes expression in the prefrontal cortex and dorsal striatum, but up-regulated these in the hippocampus, confirming the involvement of these receptors in ethanol rewarding effects. Thus, our results show that the endocannabinoid system is involved in the motivational properties of ethanol, and glutamate may control cannabinoid induced relapse into ethanol seeking behavior.https://www.mdpi.com/1422-0067/22/15/7940cannabinoidglutamateCNR1GRIN1GRIN2Aethanol relapse |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marta Marszalek-Grabska Irena Smaga Paulina Surowka Pawel Grochecki Tymoteusz Slowik Malgorzata Filip Jolanta H. Kotlinska |
spellingShingle |
Marta Marszalek-Grabska Irena Smaga Paulina Surowka Pawel Grochecki Tymoteusz Slowik Malgorzata Filip Jolanta H. Kotlinska Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) International Journal of Molecular Sciences cannabinoid glutamate CNR1 GRIN1 GRIN2A ethanol relapse |
author_facet |
Marta Marszalek-Grabska Irena Smaga Paulina Surowka Pawel Grochecki Tymoteusz Slowik Malgorzata Filip Jolanta H. Kotlinska |
author_sort |
Marta Marszalek-Grabska |
title |
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) |
title_short |
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) |
title_full |
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) |
title_fullStr |
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) |
title_full_unstemmed |
Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP) |
title_sort |
memantine prevents the win 55,212-2 evoked cross-priming of ethanol-induced conditioned place preference (cpp) |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-07-01 |
description |
The activation of the endocannabinoid system controls the release of many neurotransmitters involved in the brain reward pathways, including glutamate. Both endocannabinoid and glutamate systems are crucial for alcohol relapse. In the present study, we hypothesize that N-methyl-D-aspartate (NMDA) glutamate receptors regulate the ability of a priming dose of WIN 55,212-2 to cross-reinstate ethanol-induced conditioned place preference (CPP). To test this hypothesis, ethanol-induced (1.0 g/kg, 10% <i>w</i>/<i>v</i>, i.p.) CPP (unbiased method) was established using male adult Wistar rats. After CPP extinction, one group of animals received WIN 55,212-2 (1.0 and 2.0 mg/kg, i.p.), the cannabinoid receptor 1 (CB1) agonist, or ethanol, and the other group received memantine (3.0 or 10 mg/kg, i.p.), the NMDA antagonist and WIN 55,212-2 on the reinstatement day. Our results showed that a priming injection of WIN 55,212-2 (2.0 mg/kg, i.p.) reinstated (cross-reinstated) ethanol-induced CPP with similar efficacy to ethanol. Memantine (3.0 or 10 mg/kg, i.p.) pretreatment blocked this WIN 55,212-2 effect. Furthermore, our experiments indicated that ethanol withdrawal (7 days withdrawal after 10 days ethanol administration) down-regulated the CNR1 (encoding CB1), GRIN1/2A (encoding GluN1 and GluN2A subunit of the NMDA receptor) genes expression in the prefrontal cortex and dorsal striatum, but up-regulated these in the hippocampus, confirming the involvement of these receptors in ethanol rewarding effects. Thus, our results show that the endocannabinoid system is involved in the motivational properties of ethanol, and glutamate may control cannabinoid induced relapse into ethanol seeking behavior. |
topic |
cannabinoid glutamate CNR1 GRIN1 GRIN2A ethanol relapse |
url |
https://www.mdpi.com/1422-0067/22/15/7940 |
work_keys_str_mv |
AT martamarszalekgrabska memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT irenasmaga memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT paulinasurowka memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT pawelgrochecki memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT tymoteuszslowik memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT malgorzatafilip memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp AT jolantahkotlinska memantinepreventsthewin552122evokedcrossprimingofethanolinducedconditionedplacepreferencecpp |
_version_ |
1721218430594449408 |